¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"vinca alkaloid toxicity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® toxicity ÇÑ±Û µ¶¼º
¼³¸í   
  »ýü¿¡ À־ٶ÷Á÷ÇÏÁö ¾ÊÀº ¾à¹° ÀÛ¿ëÀ» ¸»ÇÑ´Ù. ¾à¹°À» °ú·®À¸·Î »ç¿ëÇϸé Áßµ¶À» ÀÏÀ¸Å°¸ç, ½ÉÇÑ °æ¿ì¿¡´Â Á×À½¿¡ À̸£´Âµ¥ À̴ ¾à¹°ÀÇ ±Þ¼º µ¶¼ºÀÌ´Ù. ¸¸¼º µ¶¼ºÀº ¼Ò·®À» Àå±â°£ ¹Ýº¹ ¼·ÃëÇÏ¿´À» ¶§ÀÇ µ¶¼ºÀÌ´Ù. °£, ÄáÆÏ µî ¿©·¯ Àå±â¿Í Á¶Á÷¿¡ ´ëÇÑ µ¶¼º ¿Ü¿¡, ±âÇüÀ¯¹ß¼º, ¹ß¾Ï¼º µîµµ ¾à¹°µ¶¼ºÀÌ´Ù. ¾à¹°µ¶¼ºÀÇ °­¾àÀº ±Þ¼º µ¶¼º°Ë»ç(LD50), ¸¸¼º µ¶¼º°Ë»ç, ±âÇüÀ¯¹ß°Ë»ç, ¹ß¾Ï°Ë»ç, ¹ø½Ä°Ë»ç ±âŸ ¿©·¯ µ¿¹°°Ë»ç¿¡ ÀÇÇØ ÆÇÁ¤µÈ´Ù.
¿µ¹® alkaloid ÇÑ±Û ¾ËÄ®·ÎÀ̵å
¼³¸í   
  ½Ä¹°Ã¼ ¼Ó¿¡ µé¾î Àִ Áú¼Ò¸¦ Æ÷ÇÔÇÑ ¿°±â¼º À¯±â È­ÇÕ¹°À» ÅëÆ²¾î À̸£´Â ¸». µ¶¼ºÀÌ ÀÖÀ¸¸ç ÁøÅë, ÁøÇØ, ¸¶Ãë ÀÛ¿ëÀ» ÇÑ´Ù. ´ÏÄÚÆ¾, ¸ð¸£ÇÉ, Ä«ÆäÀΠµûÀ§°¡ ÀÖ´Ù. Áú¼Ò°¡ Æ÷ÇԵǾî Àִ ¿°±â¼ºÀ̸ç, ´ëºÎºÐÀº ºñ±³Àû ¼Ò·®À¸·Î »ç¶÷À̳ª µ¿¹°¿¡ ÇöÀúÇÑ ¾à¸®ÀÛ¿ëÀ» ³ªÅ¸³»´Â À¯±âÈ­ÇÕ¹°ÀÌ´Ù. º¸ÅëÀº ½Ä¹°¿¡¼­ À¯·¡µÈ ½Ä¹°¾ËÄ®·ÎÀ̵带 ¸»ÇÑ´Ù. ÇǸ®µò-Äû³î¸°-À̼ÒÄû³î¸°-ÇǷѸ®µò-ÇÇÆä¸®µò-Àε¹-Æ®·ÎÆÇ-Ç»¸° µî °í¸®±¸Á¶¸¦ °®´Â °ÍÀÌ ¸¹°í, ´ëºÎºÐÀº ¹«»ö°áÁ¤¼º °íü·Î ½Ä¹°ÀÇ ¾×Æ÷ ³»¿¡¼­ »ê°ú¿°À» Çü¼ºÇϰí ÀÖ´Ù. ÇϳªÀÇ ½Ä¹°ÀÌ ¼öÁ¾ÀÇ ¾ËÄ®·ÎÀ̵带 Æ÷ÇÔÇϴ °æ¿ì´Â º¸ÅëÀ̸ç, ¹Ì¼÷ÇÑ ¾ç±Íºñ ¾¾ÀÇ À¯¾×¿¡¼­ ³ª¿Â ¾ÆÆí µî¿¡´Â ¾à 20Á¾·ù°¡ Æ÷ÇԵǾî ÀÖ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • oxygen toxicity
    »ê¼Òµ¶¼º
  • alkaloid
    ¾ËÄ®·ÎÀ̵å
  • alkaloid reagent
    ¾ËÄ®·ÎÀ̵å½Ã¾à
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alkaloid
    ¾ËÄ®·ÎÀ̵å
  • toxicity
    µ¶¼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alkaloid
    ¾ËÄ®·ÎÀ̵å
  • alkaloid reagent
    ¾ËÄ®·ÎÀ̵å½Ã¾à
  • free radical formation toxicity
    ÀÚÀ¯·¡µðÄ®Çü¼ºµ¶¼º
  • selective toxicity
    ¼±ÅÃÀûµ¶¼º
  • toxicity
    µ¶¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acetaldehyder toxicity
    ¾Æ¼¼Æ®¾Ëµ¥È÷µå µ¶¼º(¡­Ô¸àõ)
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º(¡­Ô¸àõ).
  • anesthetic toxicity
    ¸¶ÃëÁ¦µ¶¼º.
  • halothane, toxicity
    ÇÒ·Îź µ¶¼º
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vinca alkaloid toxicity
    ºóÄ« ¾ËÄ®·ÎÀÌµå µ¶¼º(µ¶·Â)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alkaloid
    ¾ËÄ®·ÎÀ̵å.¾à¸®À¯¿°±â, ½Ä¹°¿°±â.
  • alkaloid
    ¾ËÄ®·ÎÀ̵å.[¾à¸®]Áú¼ÒÇÔÀ¯°í¸®¿°±â.
  • alkaloid error
    ¾ËÄ®·ÎÀÌµå ¿ÀÂ÷(¡­è¦ó¬).
  • alkaloid reagent
    ¾ËÄ®·ÎÀÌµå ½Ã¾à(¡­ãËå·).
  • ergot alkaloid
    ¸Æ°¢¾ËÄ«·ÎÀ̵å.
  • acetaldehyder toxicity
    ¾Æ¼¼Æ®¾Ëµ¥È÷µå µ¶¼º(¡­Ô¸àõ)
  • acetaminophen toxicity
    ¾Æ¼¼Æ®¾Æ¹Ì³ëÆæ µ¶¼º(¡­Ô¸àõ)
  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º(¡­Ô¸àõ).
  • anesthetic toxicity
    ¸¶ÃëÁ¦µ¶¼º.
  • behavioral toxicity
    Çൿµ¶¼º(ú¼ÔÑÔ¸àõ)
  • carbon monoxide toxicity
    ÀÏ»êȭź¼Òµ¶¼º
  • chronic toxicity
    ¸¸¼ºµ¶¼º(Ø·àõÔ¸àõ).
  • citrate toxicity
    ±¸¿¬»êµ¶¼º
  • digitalis toxicity
    µðÁöÅ»¸®½ºµ¶¼º.
  • free radical formation,oxygen toxicity
    ÀÚÀ¯ ·¡µðÄ® Çü¼º, »ê¼Òµ¶¼º(ß«áÈÔ¸àõ)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vinca alkaloids
    ºóÄ« ¾ËÄ®·ÎÀ̵å
  • chronic toxicity test
    ¸¸¼º µ¶¼º½ÃÇè(Ø·àõÔ¸àõãËúÐ)
  • selective toxicity
    ¼±ÅÃÀûµ¶¼º(àÔ÷ÉîÜÔ¸àõ)
  • toxicity
    µ¶¼º(Ô¸àõ)
  • toxicity index
    µ¶¼ºÁö¼ö (Ô¸àõò¦â¦)
  • Ergot alkaloid
    ¸Æ°¢(ØêÊÇ) ¾ËÄ®·ÎÀ̵å
  • indole alkaloid
    Àε¹¾ËÄ«·ÎÀ̵å
  • isoquinoline alkaloid
    ¾ÆÀ̼ÒÅ¥³î¸° ¾ËÄ®·ÎÀ̵å
  • piperidin alkaloid
    ÇÇÆä¸®µò ¾ËÄ®·ÎÀ̵å
  • pyridine alkaloid
    ÇǸ®µò ¾ËÄ®·ÎÀ̵å
  • pyrrolidine alkaloid
    ÇǷѸ®µò ¾ËÄ®·ÎÀ̵å
  • pyrrolizidine alkaloid
    ÇǷѸ®Áöµò ¾ËÄ®·ÎÀ̵å
  • steroid alkaloid saponin
    ½ºÅ×·ÎÀÌµå ¾ËÄ®·ÎÀÌµå »çÆ÷´Ñ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • alkaloid
    ¾ËÄ®·ÎÀ̵å, À¯¿°±â, ½Ä¹°¿°±â
  • toxicity
    µ¶¼º, µ¶·Â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
EUROTOX European Committee on Chronic Toxicity Hazards
I&T intolerance and toxicity
TCLP Toxicity Characteristic Leachate Procedure [EPA battery test]
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CTC Common Toxicity Criteria
DLT Dose limiting toxicity
RRT Regimen related toxicity
TCLP Toxicity Characteristic Leaching Procedure
TIE Toxicity Identification Evaluation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • vinca alkaloid
    ºóÄ« ¾ËÄ®·ÎÀ̵å
  • alkaloid error
    ¾ËÄ®·ÎÀÌµå ¿À¹ý
  • ergot alkaloid
    ¸Æ°¢ ¾ËÄ«·ÎÀ̵å
  • opiate agonist alkaloid
    ¾ÆÆí¼º ÀÛµ¿ ¹°Áú ¾ËÄ«·ÎÀ̵å
  • Rauwolfia alkaloid
    ¶ó¿ì¿ùÇÇ¾Æ ¾ËÄ®·ÎÀ̵å
  • rauwolfia-alkaloid clozapine

    rauwolfine (¶ó¿ùÇÉ

  • acute toxicity
    ±Þ¼º Áßµ¶, ±Þ¼º µ¶¼º
  • anesthetic toxicity
    ¸¶ÃëÁ¦ µ¶¼º
  • chronic toxicity
    ¸¸¼º µ¶¼º
  • mercury toxicity
    ¼öÀº µ¶¼º
  • oxygen toxicity
    »ê¼Ò µ¶¼º
  • selective toxicity
    ¼±Åà µ¶¼º
    ¼÷ÁÖ ¼¼Æ÷¿Í ±â»ý ¼¼Æ÷¿¡ ÀÛ¿ëÇÏ´Â µ¶¼ºÀÇ »óÀÌ.
  • toxicity
    µ¶¼º, µ¶·Â
    À¯ÇØÇÑ ¼ºÁú. ƯÈ÷ À¯ÇØÇÑ ¹Ì»ý¹°À̳ª À¯µ¶ ¹°ÁúÀÇ µ¶¼ºÀÇ Á¤µµ.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
vinca alkaloid <drug, oncology> Anti-cancer drugs originally derived from the common periwinkle Catharantus roseus. Drugs of this type include vincristine, vinblastine.
(14 Oct 1997)
vinca alkaloids <chemical> A class of alkaloids from the genus of apocyanaceous woody herbs including periwinkles. They are some of the most useful antineoplastic agent.
Pharmacological action: antineoplastic agent, phytogenic, vasodilator agents.
(12 Dec 1998)
Vinca rosea A species of myrtle (family Myrtaceae) used in various parts of the world as a home remedy; two active dimeric alkaloids obtained from this plant are vinblastine and vincristine.
Synonym: periwinkle.
(05 Mar 2000)
alkaloid <chemistry, pharmacology> One of a large group of nitrogenous substances found in naturally in plants. They are usually very bitter and although the plant may be poisonous, many have extracts that are pharmacologically active.
Examples are atropine, caffeine, coniine, morphine, nicotine, quinine, strychnine. The term is also applied to synthetic substances which have structures similar to plant alkaloids, such as procaine.
(29 Sep 1997)
belladonna alkaloid Atropine and related alkaloids which are anticholinergic.
(27 Sep 1997)
ergot alkaloid-associated heart disease Heart disease caused by endomyocardial fibrosis which extends into valve structures, producing stenosis and/or regurgitation, associated with ergot alkaloid use.
(05 Mar 2000)
fixed alkaloid A nonvolatile alkaloid.
(05 Mar 2000)
acute toxicity <pharmacology> Illness resulting from a single dose or exposure to a toxic substance.
Compare: chronic toxicity.
(06 May 1997)
chronic toxicity <pharmacology> Illness caused by repeated or long-term exposure to low doses of a toxic substance.
Compare: acute toxicity.
(09 Oct 1997)
digitalis toxicity A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor.
Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels.
(27 Sep 1997)
digoxin toxicity A result of the over-accumulation of digitalis glycosides in the body. Kidney insufficiency can be a contributing factor.
Symptoms include nausea, vomiting, visual changes, blurred vision, anorexia and palpitations. Treatment is emergent as life-threatening cardiac arrhythmias are possible with higher blood levels.
(27 Sep 1997)
drug toxicity The systemic effects of a drug that are related to the overall level of the medication in the bloodstream. Drug toxicity may occur with overdosage of a medication, accumulation of the drug in the body over time or the inability of the patients body to eliminate the drug.
(27 Sep 1997)
oxygen toxicity A body disturbance resulting from breathing high partial pressures of oxygen; characterised by visual and hearing abnormalities, unusual fatigue while breathing, muscular twitching, anxiety, confusion, incoordination, and convulsions; although the mechanism for development of the condition is obscure, a disruption of enzymatic activity is likely, perhaps as a result of free radical formation.
Synonym: oxygen poisoning.
(05 Mar 2000)
toxicity The quality of being poisonous, especially the degree of virulence of a toxic microbe or of a poison.
(18 Nov 1997)
toxicity test <investigation> Controlled laboratory test to determine the toxicity of a chemical to an organism in terms of specific chemical concentrations.
An acute toxicity test establishes the concentration required to kill a predetermined proportion of test organisms within a relatively short period of time, typically 4 days or less. A chronic toxicity test reveals the effects of a sublethal concentration applied throughout all or part of the life cycle.
(12 Jan 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • toxicity
    (À¯)µ¶¼º
  • alkaloid
    ¾ËÄ®·ÎÀ̵å
  • alkaloid
    ¾ËÄ®·ÎÀ̵å;¾ËÄ®·ÎÀ̵åÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á